Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) — With the federal authorities’s choice to disclaim Medicare protection of a complete class of Alzheimer’s remedies, in addition to the promising scientific trial information concerning lecanemab launched final month, 2022 has confirmed to be a historic yr within the battle in opposition to Alzheimer’s.
Today, through the UsIn opposition toAlzheimer’s National Summit, these points will take heart stage as Representative Anna Eshoo (D-CA), nationally acknowledged scientists, and main specialists within the area be part of UsIn opposition toAlzheimer’s chair George Vradenburg in discussing the most recent developments within the Alzheimer’s motion. The summit is being held nearly and shall be livestreamed starting as we speak at 1 p.m. ET. The second day of the summit shall be held on Thursday, October 13, additionally starting at 1 p.m. ET. To register for the occasion, click on right here.
Wednesday’s panels additionally cowl new medication presently within the pipeline, the significance of prevention and early detection, and a dialogue of equitable entry to improvements for everybody, particularly girls and other people of colour, who’re disproportionately affected by Alzheimer’s.
The day will conclude with an in-depth dialog with Representative Anna Eshoo on Congress’ position within the battle to finish Alzheimer’s.
To view the complete schedule and register to tune in stay, click on right here.
###
About UsIn opposition toAlzheimer’s
UsIn opposition toAlzheimer’s exists to beat Alzheimer’s illness. We tackle the hardest issues; deliver all of “Us” collectively to interrupt down obstacles; advocate for analysis that may velocity remedies to market; and drive adjustments that matter most to folks dwelling with the illness. We is not going to relaxation till brain-span equals lifespan – for everybody.
